|
|
H2022/CTD9547/18539
|
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/200 MG/25 MG
|
DOLUTEGRAVIR SODIUM, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7079/13566
|
DOLUTEGRAVIR 50MG , LAMIVUDINE 300MG AND TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS
|
DOLUTEGRAVIR SODIUM,LAMIVUDINE USP TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10906/21966
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE TABLETS 50 MG/300 MG/25 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR ALAFENAMIDE FUMARATE
|
DAWA LTD
|
Registered
|
Details →
|
|
|
H2019/CTD7411/14564
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG TABLETS
|
EACH FILM COATED TABLET CONTAINS 52.6 MG OF DOLUTEGRAVIR SODIUM EQUIVALENT TO 50 MG OF DOLUTEGRAVIR, 300 MG OF LAMIVUDINE USP AND 300 MG OF TENOFOVIR DISOPROXIL FUMARATE (EQUIVALENT TO 245 MG OF TENOFOVIR DISOPROXIL).
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
CTD7411
|
DOLUTEGRAVIR LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 50 MG/ 300 MG/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
H2021/CTD8639/19826
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50/300/300 MG
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
EVKA CONSULTZ LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7081/18177
|
KOCITAF
|
DOLUTEGRAVIR SODIUM/ EMTRICITABINE/ TENOFOVIR ALAFENAMIDE FUMARATE
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2025/CTD12306/26376
|
ABACAVIR (AS SULFATE), DOLUTEGRAVIR (AS SODIUM) AND LAMIVUDINE 60 MG/ 5 MG/ 30 MG DISPERSIBLE TABLETS
|
ABACAVIR SULFATE USP DOLUTEGRAVIR SODIUM LAMIVUDINE USP
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
H2022/CTD8196/17724
|
DOLUTEGRAVIR AND LAMIVUDINE 50/300 MG TABLET
|
DOLUTEGRAVIR SODIUM AND LAMIVUDINE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
-
|
Abacavir Sulphate (600mg), Dolutegravir Sodium…
|
Abacavir Sulphate, Dolutegravir Sodium and…
|
-
|
Suspended by PPB
|
Details →
|
|
|
H2017/CTD4812/195
|
DOLUTEGRAVIR, LAMIVUDINE TENOFOVIR DISOPROXIL FUMARATE
|
DOLUTEGRAVIR SODIUM, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
SIMBA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2016/CTD4043/034
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM EQUIVALENT TO DOLUTEGRAVIR 50MG
|
SIMBA PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2025/CTD10569/22997
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM
|
MICRO LABS (EA) LTD
|
Registered
|
Details →
|
|
|
CTD5930
|
DOLUTEGRAVIR TABLETS 50MG
|
DOLUTEGRAVIR SODIUM.
|
SURGILINKS LTD
|
Registered
|
Details →
|
|
|
H2017/CTD4812/195/R1
|
DOLUTEGRAVIR, LAMIVUDINE TENOFOVIR DISOPROXIL…
|
Dolutegravir Sodium, Lamivudine and Tenofovir…
|
AUROBINDO PHARMA LIMITED
|
Retained
|
Details →
|
|
|
-
|
TELATRI
|
Dolutegravir sodium, Lamivudine and Tenofovir…
|
-
|
Withheld by PPB
|
Details →
|
|
|
H2021/CTD7784/14888
|
VIROPIL
|
LAMIVUDINE USP+TENOFOVIR DISOPROXIL FUMARATE+DOLUTEGRAVIR SODIUM
|
LAZOR PHARMACEUTICALS LIMITED
|
Registered
|
Details →
|
|
|
H2022/CTD8624/19193
|
DOLUTEGRAVIR SODIUM TABLET FOR ORAL SUSPENSION (DISPERSIBLE TABLETS) 10MG
|
DOLUTEGRAVIR SODIUM
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD6525/12808
|
DOLUTEGRAVIR TABLETS 50 MG
|
DOLUTEGRAVIR SODIUM
|
UNISEL LTD
|
Registered
|
Details →
|
|
|
-
|
Dolutegravir 50 mg tablets
|
Dolutegravir sodium
|
Cipla Limited
|
Withdrawn Voluntarily by MAH
|
Details →
|